CareDx Cash on Hand 2013-2025 | CDNA
CareDx cash on hand from 2013 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
CareDx Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $261 |
| 2023 | $235 |
| 2022 | $293 |
| 2021 | $348 |
| 2020 | $225 |
| 2019 | $38 |
| 2018 | $65 |
| 2017 | $17 |
| 2016 | $17 |
| 2015 | $30 |
| 2014 | $36 |
| 2013 | $5 |
| 2012 | $6 |
|
CareDx Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $194 |
| 2025-06-30 | $186 |
| 2025-03-31 | $231 |
| 2024-12-31 | $261 |
| 2024-09-30 | $241 |
| 2024-06-30 | $229 |
| 2024-03-31 | $216 |
| 2023-12-31 | $235 |
| 2023-09-30 | $268 |
| 2023-06-30 | $283 |
| 2023-03-31 | $286 |
| 2022-12-31 | $293 |
| 2022-09-30 | $291 |
| 2022-06-30 | $306 |
| 2022-03-31 | $319 |
| 2021-12-31 | $348 |
| 2021-09-30 | $363 |
| 2021-06-30 | $370 |
| 2021-03-31 | $374 |
| 2020-12-31 | $225 |
| 2020-09-30 | $214 |
| 2020-06-30 | $211 |
| 2020-03-31 | $32 |
| 2019-12-31 | $38 |
| 2019-09-30 | $41 |
| 2019-06-30 | $43 |
| 2019-03-31 | $57 |
| 2018-12-31 | $65 |
| 2018-09-30 | $26 |
| 2018-06-30 | $16 |
| 2018-03-31 | $19 |
| 2017-12-31 | $17 |
| 2017-09-30 | $6 |
| 2017-06-30 | $9 |
| 2017-03-31 | $12 |
| 2016-12-31 | $17 |
| 2016-09-30 | $22 |
| 2016-06-30 | $17 |
| 2016-03-31 | $24 |
| 2015-12-31 | $30 |
| 2015-09-30 | $34 |
| 2015-06-30 | $37 |
| 2015-03-31 | $39 |
| 2014-12-31 | $36 |
| 2014-09-30 | $39 |
| 2014-06-30 | $8 |
| 2014-03-31 | $5 |
| 2013-12-31 | $5 |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.050B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.999B | 30.48 |
| HCA Healthcare (HCA) | United States | $107.452B | 17.79 |
| CVS Health (CVS) | United States | $105.376B | 12.12 |
| Elevance Health (ELV) | United States | $82.464B | 12.09 |
| Cencora (COR) | United States | $68.573B | 22.11 |
| Natera (NTRA) | United States | $33.416B | 0.00 |
| DiDi Global (DIDIY) | China | $23.344B | 21.57 |
| Labcorp Holdings (LH) | United States | $22.106B | 16.86 |
| Medpace Holdings (MEDP) | United States | $16.564B | 41.12 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.437B | 0.00 |
| Viatris (VTRS) | United States | $15.215B | 5.67 |
| ICON (ICLR) | Ireland | $15.077B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.687B | 13.28 |
| Revvity (RVTY) | United States | $13.234B | 24.37 |
| CochLear (CHEOY) | Australia | $12.390B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.808B | 20.82 |
| Avantor (AVTR) | United States | $8.045B | 12.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.967B | 0.00 |
| HealthEquity (HQY) | United States | $7.186B | 26.87 |
| BrightSpring Health Services (BTSG) | United States | $7.149B | 42.62 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.054B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.014B | 39.49 |
| PACS (PACS) | United States | $5.477B | 33.30 |
| Sotera Health (SHC) | United States | $5.259B | 25.36 |
| Alignment Healthcare (ALHC) | United States | $4.764B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.930B | 51.45 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.537B | 2.67 |
| Progyny (PGNY) | United States | $2.174B | 42.75 |
| Surgery Partners (SGRY) | United States | $2.088B | 26.90 |
| Establishment Labs Holdings (ESTA) | United States | $1.916B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.850B | 11.05 |
| Ardent Health (ARDT) | United States | $1.226B | 4.00 |
| Teladoc Health (TDOC) | United States | $1.123B | 0.00 |
| Nutex Health (NUTX) | United States | $1.105B | 8.45 |
| Omada Health (OMDA) | United States | $0.957B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.869B | 14.22 |
| InnovAge Holding (INNV) | United States | $0.791B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.688B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| Sonida Senior Living (SNDA) | United States | $0.592B | 0.00 |
| Enhabit (EHAB) | United States | $0.546B | 24.52 |
| CryoPort (CYRX) | United States | $0.520B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| SBC Medicals (SBC) | United States | $0.448B | 8.25 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.307B | 0.00 |
| So-Young (SY) | China | $0.291B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.172B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.125B | 0.00 |
| Biodesix (BDSX) | United States | $0.093B | 0.00 |
| DocGo (DCGO) | United States | $0.082B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.029B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.41 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |